Donald Healey
Vermogen: 29 825 $ op 30-06-2026
Vermogen: 29 825 $ op 30-06-2026
Donald Healey currently works at Adicet Bio, Inc., as Chief Technology Officer from 2020.
Dr. Healey also formerly worked at Argos Therapeutics, Inc., as Director-Immunology, KBI Biopharma, Inc., as Senior Vice President-Operations from 2017 to 2020, Opexa Therapeutics, Inc., as Chief Scientific Officer from 2013 to 2017, and British Society for Immunology, as Council Member in 1998.
Dr. Healey received his doctorate degree from the University of London and undergraduate degree from the University of Bristol.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ADICET BIO INC 0,04% | 25-03-2026 | 3.452 ( 0,04% ) | 29 825 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ADICET BIO, INC. | Hoofd Techniek/Wetenschap/O&O | 26-10-2020 |
| Bedrijven | Functie | Einde |
|---|---|---|
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Operationeel Directeur | 01-10-2020 |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Hoofd Techniek/Wetenschap/O&O | 01-02-2017 |
British Society for Immunology
British Society for Immunology Miscellaneous Commercial ServicesCommercial Services Provides membership organizations services | Corporate Officer/Principal | 01-01-1998 |
| ARGOS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 7 |
|---|---|
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Commercial Services |
Argos Therapeutics, Inc.
Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes personalized immunotherapies for the treatment of cancer and infectious diseases | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bristol
University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops autologous personalized cell therapies for the treatment of various diseases. | Health Technology |
British Society for Immunology
British Society for Immunology Miscellaneous Commercial ServicesCommercial Services Provides membership organizations services | Commercial Services |
Adicet Bio, Inc.
Adicet Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on the development of cell immunotherapies | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau